Search Details

Word: bristols (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...effect of British Pakistani and Bangladeshi upward mobility. A paper from the Department for Education and Skills found that just one percent of Bangladeshis and seven percent of Pakistanis held “high managerial or professional” jobs. Professor Tariq Modood, a sociologist at the University of Bristol, has published research that supports this; he found that Pakistani and Bangladeshi weekly earnings being the lowest of all ethnic groups in Britain...

Author: By Emily C. Ingram | Title: Stirring the Pot | 4/9/2008 | See Source »

...message resounds with blue-collar workers, fearful of what a recession could do to their already struggling bottom lines. Obama "is not saying the right things," Robin Fondacaro, 59, an equipment operator from Bristol, said before a Clinton rally in Fairless Hills Sunday. "She's telling us what we want to hear. Now whether it's true or not, time will tell...

Author: /time Magazine | Title: The Blue-Collar Battle in Pennsylvania | 4/1/2008 | See Source »

Lastly, Jason Smith, who, while serving as a federal grand juror in New Jersey in October 2003, provided information about an investigation of the Bristol-Myers Squibb Company...

Author: By Prateek Kumar, CRIMSON STAFF WRITER | Title: Plotkin To Serve Time for Fraud | 1/7/2008 | See Source »

...join the European Union in May, and Poles hope the higher profile that comes with E.U. membership will help put their country's undeserved reputation for dowdiness behind them. "The image of Poland will only improve," predicts Adrian Ellis, manager of Warsaw's plushest hotel, Le Royal Meridien Bristol ($400 a night). Business travelers are streaming into the capital, he says. "Warsaw's time will come...

Author: /time Magazine | Title: Sitting Pretty In Poland | 11/14/2007 | See Source »

Novartis, which operates in 140 countries, last year booked sales of $19 billion, up 10% from 2000. While such competitors as GlaxoSmithKline, Merck and Bristol-Myers Squibb are entering a period of declining revenue growth as patents on their major drugs expire, Novartis is poised for several years of steady double-digit expansion. This year its shares in the U.S. are up about 10%--the best performance among major drug companies--even as the Morgan Stanley Capital USA Health Care Index, a basket of big drug stocks, has fallen about 25%. Novartis is the 17th most valuable company...

Author: /time Magazine | Title: Drug Lord | 11/13/2007 | See Source »

Previous | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | Next